Kennedy Capital Management’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.3M | Sell |
75,897
-2,500
| -3% | -$109K | 0.08% | 359 |
|
|
2025
Q1 | $2.93M | Buy |
78,397
+6,090
| +8% | +$228K | 0.07% | 371 |
|
|
2024
Q4 | $3.28M | Buy |
72,307
+31,113
| +76% | +$1.41M | 0.07% | 410 |
|
|
2024
Q3 | $2.42M | Buy |
41,194
+8,755
| +27% | +$514K | 0.05% | 477 |
|
|
2024
Q2 | $1.28M | Buy |
32,439
+29,251
| +918% | +$1.15M | 0.03% | 565 |
|
|
2024
Q1 | $212K | Buy |
+3,188
| New | +$212K | ﹤0.01% | 703 |
|